Searchable abstracts of presentations at key conferences in endocrinology

ea0022p688 | Obesity | ECE2010

Early genetic rescue of extremely obese POMC-deficient mice is critical for successful recovery of normal feeding behavior and body weight

Bumaschny Viviana , de Souza Flavio , Rodriguez Vanina , Low Malcolm , Rubinstein Marcelo

A major difficulty of obesity treatments is that patients stop losing weight after a period of responsiveness and often experience a rebound. This could be caused by an impairment in energy balance circuits that becomes irreversible as obesity progresses. To test this hypothesis, we generated a reversible knockout-mouse model of early onset obesity. These mice are unable to express the proopiomelanocortin gene (Pomc) in hypothalamic neurons (CNS-Pomc−/...

ea0020p366 | Diabetes and Cardiovascular | ECE2009

A comparison between adhesion molecules (as markers of inflammation) in identifying cardiovascular disease in postmenopausal women

Sitar-Taut Adela-Viviana , Cebanu Mirela , Soritau Olga , Stugren Carmen , Pop Dana , Zdrenghea Dumitru Tudor

Background: There are increasing evidences that inflammation is involved in the pathophysiology of both coronary heart disease and cerebrovascular disease. Adhesion molecules have been advocated as a marker of inflammation.Objectives: To evaluate the capacity of inflammation’s markers (sICAM1, sVCAM1) to identify cardiovascular disease, comparing adhesion molecules with a standard diagnosis of cardiovascular disease.Methods: W...

ea0014p72 | (1) | ECE2007

Polymorphisms of von Willebrand factor gene promoter modulate the corticosteroid-mediated increase of VWF levels in Cushing’s syndrome.

Daidone Viviana , Sartorello Francesca , Albiger Nora , Mantero Franco , Pagnan Antonio , Casonato Alessandra , Scaroni Carla

Cushing’s syndrome (CS) is associated with hypercoagulable state, mainly dependent on corticosteroid-induced increase of von Willebrand factor (VWF) levels, even though this does not affects all patients. In normals plasma VWF levels are genetically determined by ABO blood groups and polymorphisms G/C −1793, C/T −1234, A/G −1185, G/A −1050 of VWF promoter. These SNPs segregate as haplotype 1 (G/C/A/G) and haplotype 2 (C/T/G/A) with genotype 1/1 (GG...

ea0081ep628 | General Endocrinology | ECE2022

Exposure to the endocrine disruptor cadmium alters human aortic endothelial cells homeostasis

Catanzaro Giuseppina , Sabato Claudia , Bimonte Viviana Maria , Spinello Zaira , Po Agnese , Besharat Zein Mersini , Vacca Alessandra , Migliaccio Silvia , Ferretti Elisabetta

Cardiovascular diseases (CVDs) represent a complex and multifactorial issue that results from a combination of behavioural, genetic and environmental factors. Toxic metal contaminants, many of which act as endocrine disruptors (EDs), have been identified as potential risk factors for CVDs. Among EDs Cadmium (Cd), present both in cigarettes and in food, has been suggested to be cytotoxic on vascular endothelium, likely leading to blood pressure increase and vascular inflammatio...

ea0090ep1035 | Thyroid | ECE2023

Graves’ Disease Hiding Metastatic Papillary Thyroid Carcinoma - case report-

Musat Madalina , Septar AIlin , Boanta Roxana , Goldstein Andrei , Terzea Dana , Ioachim Dumitru , Schipor Sorina , Muresan Andrei , Niculescu Dan , Elian Viviana

The coexistence of Graves disease (GD) and thyroid carcinoma used to be considered uncommon, but association between the two is being progressively acknowledged. Case report: We present the case of a 69-year-old woman with a 10 year history of GD who was referred to our clinic for fatigue, sweating, palpable cervical mass and weight loss. She was treated only in the previous 5 months with block and replace therapy. Laboratory workup at admission showed s...

ea0049gp178 | Pituitary | ECE2017

Sleep patterns in patients with non-functional GHRH receptor

Oliveira Francielle T , Salvatori Roberto , Marcondes Jose , Macena Larissa B , Oliveira-Santos Alecia A , Faro Augusto C N , Campos Viviane C , Oliveira Carla R P , Costa Ursula M M , Aguiar-Oliveira Manuel H

Hypothalamic GH releasing hormone (GHRH) has hypnotic actions by increasing slow wave sleep (SWS) (non-rapid eye movement sleep, non-REM), which account for about 75% of sleep. Conversely, GH may stimulate the rapid eye movement sleep (REM). Patients with GH deficiency (GHD) often exhibit sleep problems leading to daytime fatigue and reduced quality of life (QoL). We have described a cohort of patients with isolated GHD (IGHD) due to GHRH resistance caused by a homozygous null...

ea0049ep949 | Pituitary - Clinical | ECE2017

Ocular findings in adult subjects with congenital, lifetime, isolated, untreated growth hormone deficiency

Faro Augusto C N , Pereira-Gurgel Virginia M , Salvatori Roberto , Campos Viviane C , Melo Gustavo B , Oliveira Francielle T , Oliveira-Santos Alecia A , Oliveira Carla R P , Pereira Francisco A , Hellstrom Ann , Oliveira-Neto Luis A , Aguiar-Oliveira Manuel H

Ocular function is fundamental for environmental adaptation and survival capacity. Growth factors are thought to be necessary to reach a mature eyeball and consequent adequate vision. However, the consequences of the deficiency of circulating growth hormone (GH) and its effector insulin-like growth factor I (IGF-I) on the physical aspects of the human eye are still debated. A model of untreated isolated GH deficiency (IGHD) may clarify this issue. The aim of this study was to ...

ea0021p229 | Growth and development | SFEBES2009

Familial growth hormone deficiency – response to growth hormone therapy and analysis of the GH-1 and GHRH-R genes

Hannon Mark , Crowley Vivian , O'Halloran Domhnall

Familial isolated growth hormone deficiency is exceedingly rare. We present two siblings of non-consanguineous parents with this syndrome and describe their response to growth hormone therapy. We have also carried out a mutational analysis of their GH1 and GHRH-R genes.A mutation scan of the entire coding region and flanking intronic sequences of GH-1 and GHRH-R was undertaken in both index cases and parents. GH1 and GHRH-R mu...

ea0081p395 | Environmental Endocrinology | ECE2022

The endocrine disruptor cadmium affects both ERα+ and ERα- breast cancer cell lines

Maria Bimonte Viviana , Sabato Claudia , Trocchianesi Sofia , Mersini Besharat Zein , Po Agnese , catanzaro giuseppina , Falcone Italia , Fabi Alessandra , Bei Roberto , Milella Michele , Vacca Alessandra , Ferretti Elisabetta , Migliaccio Silvia

The highly toxic heavy metal Cadmium (Cd) is widely spread in the environment and could exert estrogen-like activity in tissues including breast. Previous studies demonstrated that Cd binds to estrogen receptor α positive (ERα+) breast cancer (BC) cells. In this new study, we evaluated effects of Cd on both ERα+ and ERα negative (ERα-) BC models with the aim to further characterize the mechanisms involved in Cd-related BC carcinogenesis. Specifically, ...

ea0090p461 | Reproductive and Developmental Endocrinology | ECE2023

Extremely high testosterone level in a woman without virilization signs. Is it only laboratory pitfalls?

Ostrovsky Viviana , Ulman Mira , Hemi Rina , Lurie Samuel , Hazan Inon , Ben Ari Alon , Sukmanov Oleg , Schiller Tal , Kirzhner Alena , Zornitzki Taiba

Introduction: High androgen levels and infertility in reproductive women, beyond the most common cause of polycystic ovary syndrome (PCOS), is often a challenge diagnosis. Ovarian steroid cell tumor is considered a rare subtype of hormone-secreting ovarian tumor, accounting for about 0.1% of all ovarian tumors.Aim: To report a case of extremely high testosterone levels in a woman with secondary amenorrhea but without signs of virilization, and describe d...